Lothar Huebsch
Overview
Explore the profile of Lothar Huebsch including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
39
Citations
446
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Halpenny M, William N, Elmoazzen H, Giulivi A, Martin L, Perron D, et al.
Cytotherapy
. 2021 Oct;
24(3):223-224.
PMID: 34688545
No abstract available.
2.
Chruscinski A, Juvet S, Moshkelgosha S, Renner E, Lilly L, Selzner N, et al.
Transplantation
. 2021 May;
106(3):562-574.
PMID: 34049362
Background: Primary sclerosing cholangitis (PSC) is an indication for liver transplantation, but recurrence after liver transplantation is associated with poor outcomes often requiring repeat transplantation. We investigated whether autologous hematopoietic...
3.
Buchan C, Li H, Herry C, Scales N, MacPherson P, Faller E, et al.
Transplant Cell Ther
. 2021 May;
28(3):166.e1-166.e8.
PMID: 33964517
Early warning of infection is critical to reduce the risk of deterioration and mortality, especially in neutropenic patients following hematopoietic stem cell transplantation (HCT). Given that heart rate variability (HRV)...
4.
Masson-Roy J, Breiner A, Warman-Chardon J, Pringle C, Allan D, Bredeson C, et al.
Can J Neurol Sci
. 2021 Feb;
48(6):760-766.
PMID: 33631093
Background: Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) refractory to conventional therapy can lead to marked disability and represents a therapeutic challenge. Objective: To report five cases of treatment-refractory disabling CIDP treated...
5.
Yahya A, Radhwi O, Sobh M, Huebsch L, MacDonald D
Clin Lymphoma Myeloma Leuk
. 2021 Feb;
21(4):e423-e427.
PMID: 33558203
Background: In Canadian adults, follicular lymphoma (FL) is the most common subtype of non-Hodgkin lymphomas. Approximately 20% of patients with FL experience progression of disease within 2 years of first-line...
6.
Khalife R, Aw A, Duffett L, Radhwi O, Lacasse L, Huebsch L, et al.
Clin Lymphoma Myeloma Leuk
. 2021 Feb;
21(6):e493-e496.
PMID: 33558201
No abstract available.
7.
Heelan F, Mallick R, Bryant A, Radhwi O, Atkins H, Huebsch L, et al.
Biol Blood Marrow Transplant
. 2020 Mar;
26(7):1298-1302.
PMID: 32165325
Anti-thymocyte globulin (ATG) is used to reduce the incidence and severity of graft-versus-host disease (GVHD) with hematopoietic cell transplantation, yet optimum dosing has yet to be determined. We have previously...
8.
Altouri S, Allan D, Atkins H, Fulcher J, Huebsch L, Kekre N, et al.
Bone Marrow Transplant
. 2020 Jan;
55(7):1454-1456.
PMID: 31992848
No abstract available.
9.
Li T, Mallick R, McCurdy A, Mulpuru S, Huebsch L, Bredeson C, et al.
Clin Lymphoma Myeloma Leuk
. 2018 Dec;
19(2):68-72.
PMID: 30552014
Introduction: Despite the risk of morbidity and mortality associated with autologous hematopoietic cell transplantation (ASCT), there are no clear guidelines as to how to screen for these risks. This study...
10.
Visram A, Aziz J, Bryant A, Zhang T, Cieniak C, Hamelin L, et al.
Biol Blood Marrow Transplant
. 2018 Jul;
24(12):2466-2470.
PMID: 30036572
Relapse after allogeneic hematopoietic cell transplantation (HCT) for acute leukemia can be reduced when pursued early after first complete remission. The impact of donor age and donor relatedness on the...